1. Early decreases in liver stiffness measurements in chronic hepatitis B and liver fibrosis were primarily due to reduced inflammation.
2. Liver enzymes significantly decreased, and most patients experienced reductions in liver stiffness measurements.
3. Improved liver inflammation scores were observed, but improvement in fibrosis was less pronounced.
4. The study highlighted the impact of inflammation on stiffness measurements and the need for long-term studies to refine fibrosis monitoring and treatment response strategies.
5. Virologic suppression was achieved in most patients, with liver function markers and noninvasive fibrosis indices significantly improving.

Source: Journal of Clinical Gastroenterology